Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

Παρόμοια τεκμήρια

• Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
  ανά: Kett, Daniel H, κ.ά.
  Έκδοση: (2011)
• Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by <it>Candida albicans</it>: a multivariate analysis of factors associated with improved outcome
  ανά: Reisman Arlene L, κ.ά.
  Έκδοση: (2011-09-01)
• Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
  ανά: Reboli, Annette C, κ.ά.
  Έκδοση: (2011)
• Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia
  ανά: Krause, David S., κ.ά.
  Έκδοση: (2004)
• Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
  ανά: Ruhnke, M, κ.ά.
  Έκδοση: (2011)